期刊文献+

直肠癌PPAR γ的表达及其相关性研究 被引量:1

Study on expression and correlation of PPARγ in rectal cancer
下载PDF
导出
摘要 目的研究直肠癌组织中过氧化物酶体增殖物激活受体γ(PPARγ)的表达情况。方法采用免疫组织化学SABC法,检测40例直肠癌组织、10例直肠腺瘤组织和10例直肠旁正常组织切片中的PPARγ的表达,结合病理学分型、临床分期、放疗敏感性、淋巴结转移、生存期探讨其意义。结果 PPARγ在直肠癌中含量明显高于腺瘤组织及直肠旁正常组织(P<0.05);PPARγ在直肠癌中的表达与直肠癌分期、放疗敏感性、淋巴结转移、5年生存期密切相关(P<0.05)。结论直肠癌组织中PPARγ表达与临床相关因素关系密切,对直肠癌预后的判断和临床治疗具有重要意义。 Objective To investigate the expression of PPARγ in colorectal cancer tissue. Methods The expressions of PPARγ in 40 cases of colorectal cancer tissue, 10 cases of coloreetal adenomas tissues and 10 cases of normal tissue adjacent to the rectum, were examined used SABC immunohistochemical method. Results PPARγ was expressed in each group with different levels, hut the expression rates of PPARγ in rectal carcinoma was significantly higher than those in colorectal adenomas tissues and normal tissue adjacent to the rectum(P〈0.05).It was well associated with the clinic stages ,radiosensitivity ,lymphatic metastasis and 5-year survival time(P〈0.05). Conclusion PPAR gamma abnormal expression in colorectal cancer tissue, and its closely associated with clinical relevant factors of colorectal cancer prognosis judgement and clinical treatment has certain guiding significance.
出处 《中国现代医生》 2014年第5期26-27,30,共3页 China Modern Doctor
基金 广东省佛山市卫生局医学研究立项(2011037)
关键词 直肠癌 过氧化物酶体增殖物激活受体γ(PPARγ) 放疗敏感性 Ervical carcinoma Peroxisome proliferator-activated receptor γ(PPARγ) Radio-sensitivity
  • 相关文献

参考文献10

  • 1Francois Y. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial[J]. J Clin Oncol, 1999, 17 (8) :2396.
  • 2Ferruzzi P, Ceni E, Tarocchi M, et ah Thiazolidine- diones inhibit growth and invasiveness of the human a- drenocortical cancer cell line H295R[J].J Clin Endocrinol Metab,2005,90(3) : 1332-1339.
  • 3Guan Y,Zhang Y, Breyer MD. The Role of PPARs in the transcriptional control of cellular processes[J]. Drug News Perspect,2002,15: 147-154.
  • 4Varley CL, Stahlschmidt J, Lee WC, et al. Role of PPARgamma and EGFR signalling in the urothelial termi- nal differentiation programme[J]. J Cell Sci, 2004, 117 (Pt 10) :2029-2036.
  • 5Schimd T, Zhou J, Kohl R,et al. P300 relieves P53-e- voked transcriptional repression of hypoxia-inducible fac- tor(HIF-1)[J]. Biochem, 2004,380:289-295.
  • 6Varley CL, Stahlschmidt J, Smith B, et al. Activation of peroxisome proliferator-activated receptor-gamma revers- es squamous metaplasia and induces transitional differen- tiation in normal human urothelial cells[J]. Am J Pathol, 2004, 164 : 1789-1798.
  • 7Varley CL, Garthwaite MA, Cross W, et al. PPARgam- ma-regulated tight junction development during human urothelial cytodifferentiation[J]. J Cell Physiol, 2006, 208: 407 -417.
  • 8Strand DW,Jiang M,Murphy TA,et aI.PPARg isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation[J]. Cell Death Dis,2012,3 : 361.
  • 9Galli A, Ceni E,Crabb DW,et al. Antldiabetic thiazo- lidinediones inhibit invasiveness of pancreatic cancer cells via PPAR-gamma independent mechanisms[J]. Gut,2004, 53(11 ) : 1688-1697.
  • 10Suzuki H, Tomida A,Tsuruo T, et al. Dephosphorylated hypoxia induced factor lc~ as a mediator of P53 depen- dent apoptosis during hypoxia[J]. Oncogene,2001, 20: 5778-5779.

同被引文献9

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部